CD4 and myeloid sarcoma: Interestingly, DICAM is particularly expressed on circulating CD4+ T lymphocytes of MS patients and, together with its ligand αVβ3, is upregulated on lesion-associated BBB, further suggesting a role for this molecules in Th cell migration during EAE and MS (Du et al., 2016; Charabati et al., 2022).